| __timestamp | Catalyst Pharmaceuticals, Inc. | Ligand Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 10117774 | 12122000 |
| Thursday, January 1, 2015 | 11801342 | 13380000 |
| Friday, January 1, 2016 | 11369941 | 21221000 |
| Sunday, January 1, 2017 | 11375237 | 26887000 |
| Monday, January 1, 2018 | 19919204 | 27863000 |
| Tuesday, January 1, 2019 | 18842752 | 55908000 |
| Wednesday, January 1, 2020 | 16496715 | 59392000 |
| Friday, January 1, 2021 | 16936000 | 69012000 |
| Saturday, January 1, 2022 | 19789000 | 36082000 |
| Sunday, January 1, 2023 | 93150000 | 24537000 |
Unlocking the unknown
In the competitive world of pharmaceuticals, innovation is key. Over the past decade, Catalyst Pharmaceuticals, Inc. and Ligand Pharmaceuticals Incorporated have shown distinct strategies in their research and development (R&D) investments. From 2014 to 2023, Ligand Pharmaceuticals consistently outspent Catalyst Pharmaceuticals in R&D, peaking in 2021 with an investment nearly four times that of Catalyst. However, in a surprising turn, Catalyst Pharmaceuticals dramatically increased its R&D spending by over 370% in 2023, surpassing Ligand for the first time. This shift highlights Catalyst's commitment to innovation and could signal a strategic pivot in their business model. As the pharmaceutical landscape evolves, these investments will likely play a crucial role in determining which company leads in groundbreaking treatments and therapies.
Eli Lilly and Company or Ligand Pharmaceuticals Incorporated: Who Invests More in Innovation?
Research and Development Investment: Johnson & Johnson vs Catalyst Pharmaceuticals, Inc.
Comparing Innovation Spending: Amgen Inc. and Ligand Pharmaceuticals Incorporated
Comparing Innovation Spending: Gilead Sciences, Inc. and Catalyst Pharmaceuticals, Inc.
R&D Insights: How Bio-Techne Corporation and Catalyst Pharmaceuticals, Inc. Allocate Funds
Research and Development: Comparing Key Metrics for Exelixis, Inc. and Ligand Pharmaceuticals Incorporated
Research and Development Investment: Pharming Group N.V. vs Catalyst Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Corcept Therapeutics Incorporated and Catalyst Pharmaceuticals, Inc.
Comparing Innovation Spending: CymaBay Therapeutics, Inc. and Catalyst Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Viking Therapeutics, Inc. and Ligand Pharmaceuticals Incorporated
Research and Development: Comparing Key Metrics for Catalyst Pharmaceuticals, Inc. and Evotec SE
Comparing Innovation Spending: Ligand Pharmaceuticals Incorporated and Evotec SE